QSAR study and VolSurf characterization of human intestinal absorption of drugs

被引:0
作者
Hu, GX [1 ]
Shang, ZC [1 ]
Zou, JW [1 ]
Yang, GM [1 ]
Yu, QS [1 ]
机构
[1] Zhejiang Univ, Dept Chem, Hangzhou 310027, Zhejiang, Peoples R China
关键词
human intestinal absorption; QSAR; VolSurf; principal component analysis (PCA); partial least squares (PLS);
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The prediction of human intestinal absorption is a major goal in the design, optimization, and selection of candidates for the development of oral drugs. In this study, a computerized method (VolSurf with GRID) was used as a novel tool for predicting human intestinal absorption of test compound, and for determining the critical molecular properties needed for human intestinal absorption. The tested molecules consisted of 20 diverse drug-like compounds. Partial least squares (PIS) discriminant analysis was used to correlate the experimental data with the theoretical molecular properties of human intestinal absorption. A good correlation (r(2) = 0.95, q(2) = 0.86) between the molecular modeling results and the experimental data demonstrated that human intestinal absorption could be predicted from the three-dimensional (3D) molecular structure of a compound. Favorable structural properties identified for the potent intestinal absorption of drugs; included strong imbalance between the center of of a molecule and the barycentre of its hydrophilic and hydrophobic regions and a definitive hydrophobic region as well as less hydrogen bonding donors and acceptors in the molecule.
引用
收藏
页码:238 / 243
页数:6
相关论文
共 50 条
  • [41] Triazoloquinazolines as human A3 adenosine receptor antagonists: A QSAR study
    Kim, Dooil
    Hong, Suk-In
    Lee, Dae-Sil
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2006, 7 (11): : 485 - 496
  • [42] A QSAR Study on the Biological Activities of Polyamines as Anti-alzheimer Drugs by Monte Carlo Optimization
    Ghasemi, Ghasem
    JOURNAL OF SCIENTIFIC & INDUSTRIAL RESEARCH, 2019, 78 (05): : 323 - 327
  • [43] Synthesis, characterization, crystal structures, QSAR study and antibacterial activities of organotin bisphosphoramidates
    Gholivand, Khodayar
    EbrahimiValmoozi, Ali Asghar
    Gholami, Akram
    Dusek, Michal
    Eigner, Vaclav
    Abolghasemi, Sara
    JOURNAL OF ORGANOMETALLIC CHEMISTRY, 2016, 806 : 33 - 44
  • [44] A novel approach for prediction of intestinal absorption of drugs in humans based on hydrogen bond descriptors and structural similarity
    Raevsky, OA
    Schaper, KJ
    Artursson, P
    McFarland, JW
    QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIPS, 2002, 20 (5-6): : 402 - 413
  • [45] Formation of a Bile Salt-Drug Hydrogel to Predict Human Intestinal Absorption
    Shokry, Dina S.
    Waters, Laura J.
    Parkes, Gareth M. B.
    Mitchell, John C.
    Snowden, Martin J.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 108 (01) : 279 - 287
  • [46] Human intestinal absorption of imidacloprid with Caco-2 cells as enterocyte model
    Brunet, JL
    Maresca, M
    Fantini, J
    Belzunces, LP
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2004, 194 (01) : 1 - 9
  • [47] Lipophilicity and Biological Activity Study of Several Caspofungin Antifungal Drugs Using QSAR and Monte Carlo Methods
    Nikkar, Maria
    Kordabadi, Robabeh Sayyadi
    Alizadeh, Omid
    Ghasemi, Ghasem
    IRANIAN JOURNAL OF CHEMISTRY & CHEMICAL ENGINEERING-INTERNATIONAL ENGLISH EDITION, 2022, 41 (12): : 4132 - 4150
  • [48] QSAR study on the inhibition of the human carbonic anhydrase cytosolic isozyme hCA VII
    Singh, Shalini
    JOURNAL OF THE INDIAN CHEMICAL SOCIETY, 2013, 90 (02) : 245 - 252
  • [49] A Novel 3D Molecular Structural Characterization Method Applied in QSAR Study
    Tong, Jianbo
    Chen, Yang
    Liu, Shuling
    Che, Ting
    Xu, Xiameng
    REVISTA DE CHIMIE, 2013, 64 (07): : 707 - 712
  • [50] Construction of a Quantitative Structure Activity Relationship (QSAR) Model to Predict the Absorption of Cephalosporins in Zebrafish for Toxicity Study
    Liu, Ying
    Zhang, Xia
    Zhang, Jingpu
    Hu, Changqin
    FRONTIERS IN PHARMACOLOGY, 2019, 10